These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2355800)

  • 1. Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo.
    Thomsen T; Kewitz H
    Life Sci; 1990; 46(21):1553-8. PubMed ID: 2355800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans.
    Thomsen T; Bickel U; Fischer JP; Kewitz H
    Eur J Clin Pharmacol; 1990; 39(6):603-5. PubMed ID: 2095347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the acetylcholinesterase inhibitor galanthamine.
    Sramek JJ; Frackiewicz EJ; Cutler NR
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2393-402. PubMed ID: 11060814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases.
    Gulcan HO; Orhan IE; Sener B
    Curr Pharm Biotechnol; 2015; 16(3):252-8. PubMed ID: 25483718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the molecular mechanism of action of galanthamine, an antagonist of nondepolarizing muscle relaxants (author's transl)].
    Schuh FT
    Anaesthesist; 1976 Sep; 25(9):444-8. PubMed ID: 135519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galanthamine.
    Fulton B; Benfield P
    Drugs Aging; 1996 Jul; 9(1):60-5; discussion 66-7. PubMed ID: 8818586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge.
    Heinrich M; Lee Teoh H
    J Ethnopharmacol; 2004 Jun; 92(2-3):147-62. PubMed ID: 15137996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.
    Greenblatt HM; Kryger G; Lewis T; Silman I; Sussman JL
    FEBS Lett; 1999 Dec; 463(3):321-6. PubMed ID: 10606746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.
    Ezoulin MJ; Li J; Wu G; Dong CZ; Ombetta JE; Chen HZ; Massicot F; Heymans F
    Neurosci Lett; 2005 Dec; 389(2):61-5. PubMed ID: 16095823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.
    Orhan IE; Orhan G; Gurkas E
    Mini Rev Med Chem; 2011 Sep; 11(10):836-42. PubMed ID: 21762104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition.
    Bickel U; Thomsen T; Weber W; Fischer JP; Bachus R; Nitz M; Kewitz H
    Clin Pharmacol Ther; 1991 Oct; 50(4):420-8. PubMed ID: 1914378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease.
    Martinez A; Castro A
    Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The snowdrop, wellspring of galanthamine : A brief descriptive and scientific history.
    Cozanitis DA
    Wien Med Wochenschr; 2021 Jun; 171(9-10):205-213. PubMed ID: 33502637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of acetylcholinesterase activity in human brain tissue and erythrocytes by galanthamine, physostigmine and tacrine.
    Thomsen T; Kaden B; Fischer JP; Bickel U; Barz H; Gusztony G; Cervos-Navarro J; Kewitz H
    Eur J Clin Chem Clin Biochem; 1991 Aug; 29(8):487-92. PubMed ID: 1954303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Granica S; Kiss AK; Jarończyk M; Maurin JK; Mazurek AP; Czarnocki Z
    Arch Pharm (Weinheim); 2013 Nov; 346(11):775-82. PubMed ID: 24123207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
    Bores GM; Huger FP; Petko W; Mutlib AE; Camacho F; Rush DK; Selk DE; Wolf V; Kosley RW; Davis L; Vargas HM
    J Pharmacol Exp Ther; 1996 May; 277(2):728-38. PubMed ID: 8627552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use.
    Heinrich M
    Alkaloids Chem Biol; 2010; 68():157-65. PubMed ID: 20334038
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics of galanthamine as a reversible inhibitor of cholinesterase].
    Vasilenko ET; Tonkopiĭ VD
    Biokhimiia; 1974; 39(4):701-3. PubMed ID: 4441566
    [No Abstract]   [Full Text] [Related]  

  • 20. Enantiomeric resolution of galanthamine and related drugs used in anti-Alzheimer therapy by means of capillary zone electrophoresis employing derivatized cyclodextrin selectors.
    Rizzi A; Schuh R; Brückner A; Cvitkovich B; Kremser L; Jordis U; Fröhlich J; Küenburg B; Czollner L
    J Chromatogr B Biomed Sci Appl; 1999 Jul; 730(2):167-75. PubMed ID: 10448951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.